To navigate the complexities of sophisticated drug development and manufacturing, a fundamental shift toward AI-powered ...

How can we properly prepare for reshoring while ensuring we're building tomorrow's manufacturing infrastructure today?

Ascendis Pharma's Q2 2023 revenue jumped to $50.7M, driven mainly by Skytrofa sales, but net loss hit $129.9M. Liquidity concerns persist with an 11.4-month cash runway and sizable debt of $512.6M ...

Fintel reports that on June 17, 2025, Citigroup initiated coverage of NewAmsterdam Pharma Company N.V. (NasdaqGM:NAMS) with a ...

It makes sense. Google Analytics 4 (GA4) has shaken things up, cookie consent is a regulatory minefield, and capturing first-party data isn’t just a nice-to-have anymore – it’s survival.

Harshit suggests that an open ecosystem approach, with seamless data flow between touchpoints, can help brands stitch together a cohesive and personalized customer experience. Listen or read the ...

Fintel reports that on June 17, 2025, Wolfe Research initiated coverage of BridgeBio Pharma (NasdaqGS:BBIO) with a Outperform ...

Life sciences and the pharmaceutical industry are awash with data. ... Good things flow. Silicon Valley-based Treasure Data has developed a range of tools that liberate previously siloed data to ...

Martin Shkreli, the former hedge fund manager known as "Pharma Bro," defended Palantir Technologies Inc.'s valuation on Tuesday amid the company's surging stock price, projecting substantial cash ...

Circle Pharma Announces Preclinical Data Poster Presentation of CID-078, a First-and-Only-in-Class Cyclin A/B RxL Inhibitor at the 2024 World Conference on Lung Cancer. Business Wire.

Inozyme Pharma: Rare Disease Player Merits Revaluation Higher After POC Data Feb. 21, 2023 4:51 PM ET Inozyme Pharma, Inc. (INZY) Stock INZY 7 Comments 3 Likes Jonathan Faison ...

Delivers consolidated governance and real-world data exchange to unlock insights from registries and clinical trials to commercial and beyond </ Tuesday, 02 January 2024 12:17 GMT عربي ...